Diagnostic scheme may be developed on a national or global level, but may b
e varied depending on the local conditions. In this article, the difference
s between French and North American gynecologic cytology are discussed. Thi
s article emphasizes the training, diagnostic, technologic, and regulatory
differences that exist in France. By studying such differences, local pract
ices can learn potential benefits and why their currently used systems may
be optimal.